Securities code: Zhejiang Gongdong Medical Technology Co.Ltd(605369) securities abbreviation: Zhejiang Gongdong Medical Technology Co.Ltd(605369) Announcement No.: 2022011 Zhejiang Gongdong Medical Technology Co.Ltd(605369)
Announcement of resolutions of the 10th meeting of the second board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Meetings of the board of supervisors
Zhejiang Gongdong Medical Technology Co.Ltd(605369) (hereinafter referred to as “the company”) the 10th meeting of the second session of the board of supervisors was held by on-site voting in the conference room on the third floor of the company on April 15, 2022. The notice of the meeting was sent by hand or email on April 3, 2022. The meeting was presided over by Mr. Zhang Jingxiang, chairman of the board of supervisors. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The convening and convening of this meeting comply with the relevant provisions of the company law and the articles of association, and the contents of the resolution are legal and valid.
2、 Deliberation at the meeting of the board of supervisors
(I) the proposal on the company’s 2021 annual report and its summary was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The company’s 2021 annual report and the company’s 2021 annual report summary.
(II) the proposal on the work report of the board of supervisors in 2021 was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
(III) the proposal on the company’s internal control evaluation report in 2021 was considered and adopted. The voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) 2021 annual internal control evaluation report of the company.
4、 The proposal on the 2021 annual financial statement of the company was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
5、 The proposal on the company’s profit distribution plan for 2021 was reviewed and approved
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement of profit distribution plan for 2021 (Announcement No.: 2022012).
6、 The proposal on renewing the appointment of financial audit institutions was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on renewing the appointment of accounting firms (Announcement No.: 2022013).
(VII) the proposal on the special report on the annual deposit and use of raised funds (2021) was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Special report on the annual storage and use of raised funds (2021) (Announcement No.: 2022014). (VIII) the proposal on confirming the daily connected transactions of the company in 2021 and the expected daily connected transactions of the company in 2022 was reviewed and approved
Voting results: 3 in favor, 0 against and 0 abstention.
According to the company’s business needs, in 2022, the company expects to have daily related party transactions with the related party Zhejiang Evergrande Medical Devices Co., Ltd. with a total amount of no more than 21 million yuan.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on expected daily connected transactions in 2022 (Announcement No.: 2022015).
(IX) the proposal on the remuneration of the company’s supervisors was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
(x) the company’s report for the first quarter of 2022 was reviewed and approved
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The first quarter report of the company in 2022.
It is hereby announced.
Zhejiang Gongdong Medical Technology Co.Ltd(605369) board of supervisors April 18, 2022
